
Bluepear is an AI-powered brand and affiliate monitoring platform designed to help marketing teams protect their brand in paid search. It continuously monitors branded search queries 24/7 across all geographies, device types, and search engines — including Google, Bing, Yahoo!, and Yandex — to detect unauthorized use of branded keywords, ad hijacking, coupon code abuse, and trademark violations by affiliates and competitors.
The platform was built by affiliate marketing specialists who faced these challenges firsthand. Manual audits didn't scale and violations were easy to miss. Bluepear automates detection, uncovers cloaked affiliate websites, captures full redirect chains with screenshots as evidence, and generates structured compliance reports. All findings are centralized in one dashboard with instant alerts via Slack, Telegram, or email.
Key features include brand bidding protection, ad hijacking detection, an uncloaking tool that reveals actual landing pages behind cloaked links, coupon code monitoring, competitor keyword and ad copy tracking, progress status tracking for violation resolution, policy-based filtering by violation type, custom data exports, and research tools that compare advertiser dynamics and visibility rates over time. Global coverage extends down to city level across all countries.
Bluepear serves Paid Search/PPC teams, affiliate managers, and marketing compliance teams at brands in e-commerce, travel & ticketing, pharma, health & beauty, marketing agencies, iGaming, online finance, and IT/SaaS. Customers include Wargaming, vidaXL, Proton, MoneyGram, IQ Option, and Kilo Health.
The platform is accessible on web, iOS, Android, and via API. It offers a 7-day free trial with no credit card required, transparent usage-based pricing, and setup in minutes.
Learn more

Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more
Qualcy QMS
Qualcy Biomed's quality management system (QMS) software is tailored specifically for biomedical enterprises, such as those in biotechnology and pharmaceuticals, to effectively handle QMS documentation in line with FDA and ISO 13485 standards. It ensures adherence to 21 CFR Part 820 and incorporates essential features like electronic signatures, audit trails, and compliance with 21 CFR Part 11. Additionally, the software facilitates the management of document change control, complaint handling, audits, corrective and preventive actions (CAPA), non-conformance records, and training records, among other critical functions, ensuring a comprehensive solution for quality management. This robust platform ultimately supports organizations in maintaining high standards of compliance and operational efficiency in their quality processes.
Learn more
IntegriChain ICyte
Life sciences organizations, irrespective of their scale or intricacy, rely on the ICyte platform to improve their processes for entering pharmaceutical markets and commercializing therapies. This platform provides biotech and pharmaceutical manufacturers with outstanding services, which encompass the collection of channel and patient data, management of pricing and contracts, gross-to-net forecasting, and accrual systems, along with specialized solutions that promote launch effectiveness and pricing transparency. By leveraging ICyte, both pharmaceutical and biotech companies can markedly improve their market access abilities by rapidly transforming complex data related to patients, payers, transactions, and channels into actionable insights. Moreover, ICyte delivers analytics-as-a-service, enabling the implementation of standardized models and metrics across a variety of applications, data sources, and analytical needs. The platform is designed to incorporate key performance indicators (KPIs) specifically tailored for organizations in the life sciences sector. In addition, it boasts sophisticated analytics capabilities such as forecasting, scenario modeling, and a machine learning-powered recommendation engine, all of which support firms in making informed, data-driven choices. ICyte's comprehensive approach not only streamlines operations but also equips organizations with the tools necessary to adeptly navigate the intricate landscape of the pharmaceutical industry. As a result, companies utilizing ICyte can better position themselves for success in a competitive marketplace.
Learn more